Indonesia: Kimia Farma in JV with Korea’s Sungwun Pharmacopia; China’s Wanda Group, Rotchschild among bidders for Hanson shares

State-owned PT Kimia Farma Tbk (KAEF), one of Indonesia largest pharmaceutical companies, has agreed to establish a joint venture (JV) with South Korea’s Sungwun Pharmacopia to build a drug ingredients plant in West Java. While, Wanda Group, China’s largest property conglomerate, and global financial group Rothschild are among the bidders for shares in locally listed property firm PT Hanson International Tbk (MYRX).